These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 9800243

  • 1. Diagnosis and management of fetal nuchal translucency.
    Jackson M, Rose NC.
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
    Lancet; 1998 Aug 01; 352(9125):343-6. PubMed ID: 9717920
    [Abstract] [Full Text] [Related]

  • 9. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K.
    BMJ; 1992 Apr 04; 304(6831):867-9. PubMed ID: 1392745
    [Abstract] [Full Text] [Related]

  • 10. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM, Whitlow BJ, Lazanakis M, Kadir RA, Chatzipapas I, Economides DL.
    Ultrasound Obstet Gynecol; 2000 Oct 04; 16(5):402-6. PubMed ID: 11169322
    [Abstract] [Full Text] [Related]

  • 11. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
    Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G.
    Obstet Gynecol; 2001 Jun 04; 97(6):916-20. PubMed ID: 11384696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sonographic screening for fetal aneuploidy: first trimester.
    Souter VL, Nyberg DA.
    J Ultrasound Med; 2001 Jul 04; 20(7):775-90. PubMed ID: 11444737
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E, Schuchter K, Philipp K.
    Ultrasound Obstet Gynecol; 1995 Nov 04; 6(5):330-3. PubMed ID: 8590203
    [Abstract] [Full Text] [Related]

  • 17. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X, Chang Y, Cui HY, Ren CC, Yu BY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 04; 48(11):815-8. PubMed ID: 24444556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH.
    Obstet Gynecol; 1997 Dec 04; 90(6):943-6. PubMed ID: 9397108
    [Abstract] [Full Text] [Related]

  • 20. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P, Hiilesmaa V, Salonen R, Ylöstalo P.
    N Engl J Med; 1997 Dec 04; 337(23):1654-8. PubMed ID: 9385124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.